Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial.

Author: EronenMarkku, HallikainenTero, KotilainenIrma, PutkonenAnu, Repo-TiihonenEila, RyynänenOlli-Pekka, TiihonenJari, ToivonenPäivi, WahlbeckKristian

Paper Details 
Original Abstract of the Article :
There is no evidence from randomized, controlled trials that demonstrate effectiveness for any pharmacological treatment in clozapine-resistant schizophrenia. Since the introduction of chlorpromazine, all antipsychotics with proven efficacy on positive symptoms have been dopamine antagonists, but re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0006-3223(03)00524-9

データ提供:米国国立医学図書館(NLM)

Lamotrigine for Treatment-Resistant Schizophrenia

Imagine the desert of the mind, a vast and often challenging landscape to navigate. This research focuses on schizophrenia, a complex mental illness that can significantly impact a person's thoughts, feelings, and behaviors. The study investigates the effectiveness of lamotrigine, an anticonvulsant medication, for treating treatment-resistant schizophrenia, a form of schizophrenia that does not respond to traditional treatments.

Lamotrigine's Potential for Schizophrenia Treatment

The researchers conducted a randomized placebo-controlled crossover trial to evaluate lamotrigine's effectiveness in treating positive schizophrenic symptoms in patients who had not responded to clozapine, a medication considered the gold standard for treatment-resistant schizophrenia. This is like seeking a new oasis in the desert, exploring alternative pathways to alleviate the symptoms of this challenging condition.

Implications for Schizophrenia Treatment

This research suggests that lamotrigine could offer a potential treatment option for patients with treatment-resistant schizophrenia. If proven effective, lamotrigine could offer a lifeline for those navigating the desert of schizophrenia, providing hope for improved symptom management and quality of life.

Dr. Camel's Conclusion

This study delves into the complex world of schizophrenia treatment, seeking new solutions for those with treatment-resistant conditions. Lamotrigine's potential as a therapeutic agent offers a glimmer of hope in the desert of mental illness, potentially leading to better treatments and improved outcomes for patients.
Date :
  1. Date Completed 2004-02-04
  2. Date Revised 2019-08-15
Further Info :

Pubmed ID

14643092

DOI: Digital Object Identifier

10.1016/s0006-3223(03)00524-9

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.